188 related articles for article (PubMed ID: 25534140)
1. Thoughts on the progression of type 2 diabetes drug discovery.
Bhatt HB
Expert Opin Drug Discov; 2015 Feb; 10(2):107-10. PubMed ID: 25534140
[TBL] [Abstract][Full Text] [Related]
2. QSAR studies in the discovery of novel type-II diabetic therapies.
Abuhammad A; Taha MO
Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
[TBL] [Abstract][Full Text] [Related]
3. The importance of synthetic drugs for type 2 diabetes drug discovery.
Safavi M; Foroumadi A; Abdollahi M
Expert Opin Drug Discov; 2013 Nov; 8(11):1339-63. PubMed ID: 24050217
[TBL] [Abstract][Full Text] [Related]
4. Mouse models of type II diabetes mellitus in drug discovery.
Baribault H
Methods Mol Biol; 2010; 602():135-55. PubMed ID: 20012397
[TBL] [Abstract][Full Text] [Related]
5. The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future.
Bailey CJ
Clin Pharmacol Ther; 2015 Aug; 98(2):170-84. PubMed ID: 25963904
[TBL] [Abstract][Full Text] [Related]
6. Discovery and development of selective PPAR gamma modulators as safe and effective antidiabetic agents.
Doshi LS; Brahma MK; Bahirat UA; Dixit AV; Nemmani KV
Expert Opin Investig Drugs; 2010 Apr; 19(4):489-512. PubMed ID: 20367191
[TBL] [Abstract][Full Text] [Related]
7. Mouse Models of Type 2 Diabetes Mellitus in Drug Discovery.
Baribault H
Methods Mol Biol; 2016; 1438():153-75. PubMed ID: 27150090
[TBL] [Abstract][Full Text] [Related]
8. The use of insulin in elderly patients with type 2 diabetes mellitus.
Mannucci E; Cremasco F; Romoli E; Rossi A
Expert Opin Pharmacother; 2011 Dec; 12(18):2865-81. PubMed ID: 22087577
[TBL] [Abstract][Full Text] [Related]
9. Latest research and development trends in non-insulin anti-diabetics.
Cheon HG
Arch Pharm Res; 2013 Feb; 36(2):145-53. PubMed ID: 23397318
[TBL] [Abstract][Full Text] [Related]
10. Novel approaches to drug discovery for the treatment of type 2 diabetes.
Xu X; Wang G; Zhou T; Chen L; Chen J; Shen X
Expert Opin Drug Discov; 2014 Sep; 9(9):1047-58. PubMed ID: 25054271
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 antagonists for diabetes.
Mandrup-Poulsen T;
Expert Opin Investig Drugs; 2013 Aug; 22(8):965-79. PubMed ID: 23705588
[TBL] [Abstract][Full Text] [Related]
12. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
Campbell RK
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
[TBL] [Abstract][Full Text] [Related]
13. Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes.
Pfefferkorn JA
Expert Opin Drug Discov; 2013 Mar; 8(3):319-30. PubMed ID: 23289965
[TBL] [Abstract][Full Text] [Related]
14. GKAs for diabetes therapy: why no clinically useful drug after two decades of trying?
Matschinsky FM
Trends Pharmacol Sci; 2013 Feb; 34(2):90-9. PubMed ID: 23305809
[TBL] [Abstract][Full Text] [Related]
15. The importance of beta-cell management in type 2 diabetes.
Standl E
Int J Clin Pract Suppl; 2007 Jun; (153):10-9. PubMed ID: 17594389
[TBL] [Abstract][Full Text] [Related]
16. Genes associated with diabetes: potential for novel therapeutic targets?
Hara K; Kadowaki T; Odawara M
Expert Opin Ther Targets; 2016; 20(3):255-67. PubMed ID: 26458049
[TBL] [Abstract][Full Text] [Related]
17. HDL as a Target for Glycemic Control.
Waldman B; Jenkins AJ; Sullivan D; Ng MKC; Keech AC
Curr Drug Targets; 2017; 18(6):651-673. PubMed ID: 26212264
[TBL] [Abstract][Full Text] [Related]
18. Why, when and how to initiate insulin therapy in patients with type 2 diabetes.
Tibaldi J; Rakel RE
Int J Clin Pract; 2007 Apr; 61(4):633-44. PubMed ID: 17394436
[TBL] [Abstract][Full Text] [Related]
19. Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1.
Parkes DG; Mace KF; Trautmann ME
Expert Opin Drug Discov; 2013 Feb; 8(2):219-44. PubMed ID: 23231438
[TBL] [Abstract][Full Text] [Related]
20. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
